RadNet, Inc. (RDNT)
Free
No email, no account, no signup.
Pulling latest news for RadNet, Inc.…
Bull
Bear
Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99 $1.25.
Get the deep 4-model report –
Order analysis – $4.99 $1.25
Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NASDAQ
Sector
Diagnostic imaging services
Market Cap
$4.6B
Market sentiment
Sentiment has improved post-earnings as investors focus on strong top-line growth, raised guidance, and rapid Digital Health/ARR scaling, but it is tempered by the EPS miss and ongoing net losses.
Why NEUTRAL ?
Raised full-year guidance and strong same-center/volume growth strengthen the bull case, but profitability remains weak (net loss and Digital Health segment loss) and integration/investment costs (including Gleamer) may continue to pressure earnings. This warrants a reassessment rather than an immediate add/reduce.
- Hold/wait and reassess after the market digests the raised guidance; consider adding only with clearer evidence of net income/FCF conversion or a steadier margin trend.
We're already tracking RadNet, Inc. — here are the latest events we've registered
Recent News
- On May 11, 2026 RadNet reported Q1 2026: revenue $575.6M (+22.1% YoY) and adjusted EBITDA $63.3M (+36.3%). Digital Health revenue rose to $29.1M (+51.5%) and ARR increased to $96.9M. The company raised 2026 Imaging Center guidance (revenue $2.355–$2.405B; adjusted EBITDA $340–$353M; FCF $112–$122M) and highlighted the JV/rollout of DeepHealth solutions with Trinity Health’s Saint Alphonsus.
Want to know how this news affects RadNet, Inc.? Order the analysis.
Order analysis – Catalysts
Raised 2026 guidance (Imaging Centers)
Dilution Risk
Assessment: Medium
Order analysis – $4.99 $1.25
Save hours of research. $4.99 $1.25.
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
What you get
A complete express analysis — not just a signal. Delivered as a webpage in your account.
- Signal: BUY / HOLD / SELL — with clear reasoning
- Sentiment score 1–10 based on news, reports, and market data
- Risk score 1–10 (dilution, jurisdiction, execution)
- Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
- Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
- Upcoming catalysts with dates
- Sources: news, filings, market data, and investor forums
- Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of RadNet, Inc. will be delivered in the same format.
Not satisfied? Get your money back within 7 days — no questions asked.
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.